185 related articles for article (PubMed ID: 35418412)
1. Optimising the management of childhood acute diarrhoeal disease using a rapid test-and- treat strategy and/or
Pernica JM; Arscott-Mills T; Steenhoff AP; Mokomane M; Moorad B; Bapabi M; Lechiile K; Mangwegape O; Batisani B; Mawoko N; Muthoga C; Vanniyasingam T; Ewusie J; Lowe A; Bonsu JM; Gezmu AM; Smieja M; Mazhani L; Stordal K; Thabane L; Kelly MS; Goldfarb DM
BMJ Glob Health; 2022 Apr; 7(4):. PubMed ID: 35418412
[TBL] [Abstract][Full Text] [Related]
2. Rapid enteric testing to permit targeted antimicrobial therapy, with and without Lactobacillus reuteri probiotics, for paediatric acute diarrhoeal disease in Botswana: A pilot, randomized, factorial, controlled trial.
Pernica JM; Steenhoff AP; Mokomane M; Moorad B; Lechiile K; Smieja M; Mazhani L; Cheng J; Kelly MS; Loeb M; Stordal K; Goldfarb DM
PLoS One; 2017; 12(10):e0185177. PubMed ID: 28991918
[TBL] [Abstract][Full Text] [Related]
3. Randomised clinical trial: Lactobacillus reuteri DSM 17938 vs. placebo in children with acute diarrhoea--a double-blind study.
Francavilla R; Lionetti E; Castellaneta S; Ciruzzi F; Indrio F; Masciale A; Fontana C; La Rosa MM; Cavallo L; Francavilla A
Aliment Pharmacol Ther; 2012 Aug; 36(4):363-9. PubMed ID: 22680836
[TBL] [Abstract][Full Text] [Related]
4. Lactobacillus reuteri DSM 17938 effectively reduces the duration of acute diarrhoea in hospitalised children.
Dinleyici EC; ; Vandenplas Y
Acta Paediatr; 2014 Jul; 103(7):e300-5. PubMed ID: 24579935
[TBL] [Abstract][Full Text] [Related]
5. Lack of Efficacy of Lactobacillus reuteri DSM 17938 for the Treatment of Acute Gastroenteritis: A Randomized Controlled Trial.
Szymański H; Szajewska H
Pediatr Infect Dis J; 2019 Oct; 38(10):e237-e242. PubMed ID: 31033909
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of an Oral Rehydration Solution Enriched with
Maragkoudaki M; Chouliaras G; Moutafi A; Thomas A; Orfanakou A; Papadopoulou A
Nutrients; 2018 Sep; 10(9):. PubMed ID: 30200394
[TBL] [Abstract][Full Text] [Related]
7. Systematic review with meta-analysis: Lactobacillus reuteri DSM 17938 for diarrhoeal diseases in children.
Urbańska M; Gieruszczak-Białek D; Szajewska H
Aliment Pharmacol Ther; 2016 May; 43(10):1025-34. PubMed ID: 26991503
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis: Lactobacillus reuteri strain DSM 17938 (and the original strain ATCC 55730) for treating acute gastroenteritis in children.
Szajewska H; Urbańska M; Chmielewska A; Weizman Z; Shamir R
Benef Microbes; 2014 Sep; 5(3):285-93. PubMed ID: 24463209
[TBL] [Abstract][Full Text] [Related]
9. Lactobacillus reuteri DSM 17938 shortens acute infectious diarrhea in a pediatric outpatient setting.
Dinleyici EC; Dalgic N; Guven S; Metin O; Yasa O; Kurugol Z; Turel O; Tanir G; Yazar AS; Arica V; Sancar M; Karbuz A; Eren M; Ozen M; Kara A; Vandenplas Y
J Pediatr (Rio J); 2015; 91(4):392-6. PubMed ID: 25986615
[TBL] [Abstract][Full Text] [Related]
10. Lactobacillus reuteri DSM 17938 in the prevention of antibiotic-associated diarrhoea in children: protocol of a randomised controlled trial.
Kołodziej M; Szajewska H
BMJ Open; 2017 Jan; 7(1):e013928. PubMed ID: 28057659
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of Lactobacillus reuteri DSM 17938 for the Prevention of Nosocomial Diarrhea in Children: A Randomized, Double-blind, Placebo-controlled Trial.
Urbańska M; Gieruszczak-Białek D; Szymański H; Szajewska H
Pediatr Infect Dis J; 2016 Feb; 35(2):142-5. PubMed ID: 26551445
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of Lactobacillus reuteri DSM 17938 in infants and children: a review of the current evidence.
Urbańska M; Szajewska H
Eur J Pediatr; 2014 Oct; 173(10):1327-37. PubMed ID: 24819885
[TBL] [Abstract][Full Text] [Related]
13. Lactobacillus reuteri DSM 17938 in the prevention of antibiotic-associated diarrhoea in children: a randomized clinical trial.
Kołodziej M; Szajewska H
Clin Microbiol Infect; 2019 Jun; 25(6):699-704. PubMed ID: 30149135
[TBL] [Abstract][Full Text] [Related]
14. Systematic Review with Meta-Analysis:
Patro-Gołąb B; Szajewska H
Nutrients; 2019 Nov; 11(11):. PubMed ID: 31739457
[TBL] [Abstract][Full Text] [Related]
15. Tenth year reenrollment randomized trial investigating the effects of childhood probiotics and calcium supplementation on height and weight at adolescence.
Setiawan EA; Rianda D; Kadim M; Meilianawati ; Susanto F; Kok FJ; Shankar AH; Agustina R
Sci Rep; 2021 Jun; 11(1):11860. PubMed ID: 34088920
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of the prenatal administration of Lactobacillus reuteri LR92 DSM 26866 on the prevention of infantile colic: a randomized control trial.
Pourmirzaiee MA; Famouri F; Moazeni W; Hassanzadeh A; Hajihashemi M
Eur J Pediatr; 2020 Oct; 179(10):1619-1626. PubMed ID: 32372186
[TBL] [Abstract][Full Text] [Related]
17. Treating infant colic with the probiotic Lactobacillus reuteri: double blind, placebo controlled randomised trial.
Sung V; Hiscock H; Tang ML; Mensah FK; Nation ML; Satzke C; Heine RG; Stock A; Barr RG; Wake M
BMJ; 2014 Apr; 348():g2107. PubMed ID: 24690625
[TBL] [Abstract][Full Text] [Related]
18. Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis.
Shornikova AV; Casas IA; Mykkänen H; Salo E; Vesikari T
Pediatr Infect Dis J; 1997 Dec; 16(12):1103-7. PubMed ID: 9427453
[TBL] [Abstract][Full Text] [Related]
19.
García Contreras AA; Vásquez Garibay EM; Sánchez Ramírez CA; Fafutis Morris M; Delgado Rizo V
Nutrients; 2020 Sep; 12(10):. PubMed ID: 32998471
[TBL] [Abstract][Full Text] [Related]
20. Lactobacillus reuteri for Infants with Colic: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Fatheree NY; Liu Y; Taylor CM; Hoang TK; Cai C; Rahbar MH; Hessabi M; Ferris M; McMurtry V; Wong C; Vu T; Dancsak T; Wang T; Gleason W; Bandla V; Navarro F; Tran DQ; Rhoads JM
J Pediatr; 2017 Dec; 191():170-178.e2. PubMed ID: 28969890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
